High-Dose Vitamin D Supplementation and Exercise Effects on Vitamin D Metabolites in Professional Football Players (VitD-Football)

December 15, 2025 updated by: Anna Książek, Wroclaw University of Health and Sport Sciences

Effects of High-Dose Vitamin D Supplementation and Physical Exercise on Vitamin D Metabolites in Professional Football Players: A Pilot Study

This randomized, single-blind, placebo-controlled pilot study investigated the effects of high-dose vitamin D₃ supplementation and football-specific physical exercise on vitamin D metabolite concentrations in professional male football players. The study aimed to evaluate the acute response of circulating vitamin D metabolites, including 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃, following a single oral dose of 500,000 IU cholecalciferol combined with high-intensity intermittent exercise typical of competitive football.

Twenty professional football players from a Polish top-division club participated in the study. Participants were randomly assigned to either the supplementation group (SGP) receiving 500,000 IU of vitamin D₃ or the placebo group (PGP) receiving an identical volume of placebo oil. The intervention was administered 48 hours prior to an intra-squad game. Blood samples were collected at three time points: baseline (T3), pre-match (T4), and post-match (T5). The primary outcome was the change in serum 25-(OH)D₃ concentration. Secondary outcomes included changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, as well as their ratios. The study also assessed whether physical exercise modulates vitamin D metabolism.

The findings demonstrated that high-dose vitamin D₃ supplementation significantly increased serum 25-(OH)D₃ (↑198%) and 3-epi-25-(OH)D₃ (↑444%) levels, while football-specific exercise itself induced moderate increases in vitamin D metabolites. The results suggest that skeletal muscle may play a key role in vitamin D storage and release in response to exercise. The supplementation was well tolerated, with no adverse events observed.

Study Overview

Detailed Description

This pilot study was designed to explore the combined effects of high-dose vitamin D₃ supplementation and acute physical exercise on vitamin D metabolism in professional football players. The study responds to growing scientific interest in understanding how vitamin D status influences performance, recovery, and muscle function in athletes. While most previous studies have focused on chronic, low-to-moderate supplementation, this trial examined the response to a single, pharmacological dose of cholecalciferol in a controlled experimental setting.

Study Design

The study employed a randomized, single-blind, placebo-controlled, parallel-group design. Participants were randomly assigned to one of two groups:

Supplementation Group (SGP) - received a single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany);

Placebo Group (PGP) - received an identical amount of placebo (vegetable oil).

The supplementation was administered 48 hours before a standardized intra-squad football match (ISG), conducted under conditions simulating a competitive game. All players followed the same training schedule and diet during the study.

Participants

A total of 20 professional male football players (aged 18-35) from a Polish top-league club volunteered to participate. Inclusion criteria included active professional status, regular training participation, and no use of vitamin D or calcium supplements in the previous 3 months. Exclusion criteria included musculoskeletal injuries, metabolic disorders, or refusal to sign informed consent.

Measurements

Blood samples were collected at three time points:

T3: baseline (before supplementation),

T4: 48 hours post-supplementation (pre-match),

T5: immediately after the intra-squad game.

Serum concentrations of 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃ were determined using LC-MS/MS. Additional biochemical variables (hemoglobin, glucose, testosterone, cortisol, ferritin, calcium, CK) were analyzed to monitor physiological status.

Outcomes

Primary Outcome: Changes in serum 25-(OH)D₃ concentrations after supplementation and exercise.

Secondary Outcomes: Changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, metabolite ratios.

Ethics

The study was approved by the Ethics Committee of the Wroclaw University of Health and Sport Sciences (Resolution No. 1/2024, March 1, 2024). All participants signed written informed consent.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dolnyśląsk
      • Wroclaw, Dolnyśląsk, Poland, 51-612
        • Wroclaw University of Health and Sport Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Male professional football players aged 18-35 years
  2. Actively training and competing in the Polish first football league
  3. No vitamin D or calcium supplementation during the previous 3 months
  4. No injuries or illnesses affecting participation

Exclusion Criteria:

  1. Current musculoskeletal injury or illness
  2. Chronic metabolic, endocrine, or renal disorders
  3. Use of vitamin D or calcium supplements
  4. Refusal or inability to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supplementation Group (SGP)
Participants in this group received a single oral dose of 500,000 IU of vitamin D₃ (Vigantol Oil, P&G Health, Germany) 48 hours before the intra-squad football match (ISG). Blood samples were collected before supplementation and both before and after the ISG to evaluate changes in vitamin D metabolites.
A single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany) was administered 48 hours before the intra-squad football match to assess its acute effects on vitamin D metabolite concentrations.
Placebo Comparator: Placebo Group (PGP)
Participants in this group received a single oral dose of placebo oil identical in color and consistency to the vitamin D₃ solution. Blood samples were collected at the same time points as in the supplementation group to assess vitamin D metabolite changes.
A single oral dose of vegetable oil matching the vitamin D₃ solution in color and consistency was administered 48 hours before the intra-squad football match.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in serum 25(OH)D₃ concentration
Time Frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
Serum concentrations of 25(OH)D₃ will be measured using isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). The primary outcome assesses the effect of a single high-dose vitamin D₃ supplementation combined with physical exercise on 25(OH)D₃ concentration in professional football players.
Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
Changes in serum 24,25-dihydroxyvitamin D₃ [24,25(OH)₂D₃] concentration
Time Frame: Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)
To evaluate the effect of vitamin D₃ supplementation and physical exercise on 24,25(OH)₂D₃ levels using ID-LC-MS/MS.
Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in metabolite ratios (25(OH)D₃:24,25(OH)₂D₃ and 25(OH)D₃:3-epi-25(OH)D₃)
Time Frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
To assess changes in the ratios between major vitamin D metabolites as indicators of metabolic transformation rate and vitamin D turnover in response to supplementation and physical activity.
Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Książek, PhD Eng.; Associate Professor, Department of Biological Principles of Physical Activity ; Wroclaw University of Health and Sport Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2024

Primary Completion (Actual)

May 17, 2024

Study Completion (Actual)

June 24, 2024

Study Registration Dates

First Submitted

November 27, 2025

First Submitted That Met QC Criteria

December 15, 2025

First Posted (Actual)

December 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 15, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy considerations and the specific nature of the study population (professional athletes). Aggregated data are available upon reasonable request to the corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletes

Clinical Trials on Vitamin D₃

Subscribe